Company: ZURA
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0001104659-25-038042
Chunk: 27

Company: Zura Bio Ltd
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 27
---
; • reviewing related person transactions; • obtaining and reviewing a report by the independent registered public accounting firm at least annually that describes internal quality control procedures, any material issues with such procedures and any steps taken to deal with such issues when required by applicable law; and • approving or, as permitted, pre-approving, audit and permissible non-audit services to be performed by the independent registered public accounting firm. Report of the Audit Committee The Audit Committee has reviewed and discussed the audited financial statements for the fiscal year ended December 31, 2024 with management of the Company. The Audit Committee has discussed with the independent registered public accounting firm the matters required to be discussed by the applicable requirements of the Public Company Accounting Oversight Board (“PCAOB”) and the SEC. The Audit Committee has also received the written disclosures and the letter from the independent registered public accounting firm required by applicable requirements of the PCAOB regarding the independent accountants’ communications with the Audit Committee concerning independence, and has discussed with the independent registered public accounting firm the accounting firm’s independence. Based on the foregoing, the Audit Committee has recommended to the Board that the audited financial statements be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024. Amit Munshi
Steve Schoch
Jennifer Jarrett Compensation Committee As of the date of this Proxy Statement, the Compensation Committee consists of Sandeep Kulkarni, Jennifer Jarrett and Amit Munshi, with Sandeep Kulkarni serving as chair of the committee. Effective as of the date of the Annual Meeting, the members of our Compensation Committee will be Jennifer Jarrett, Amit Munshi and Dan Becker, with Dan Becker serving as chair of the committee, provided, that Dan Becker is duly elected at the Annual Meeting. The Board has determined that each of Sandeep Kulkarni, Jennifer Jarrett, Amit Munshi and Dan Becker is independent under the Nasdaq listing standards and a “non-employee director” as defined in Rule 16b-3 promulgated under the Exchange Act. The primary purpose of the compensation committee is to discharge the responsibilities of the Board in overseeing the compensation policies, plans and programs and to review and determine the compensation to be paid to executive officers, directors and other senior management, as appropriate. Specific responsibilities of the compensation committee include: • reviewing and approving the compensation of the chief executive officer, other executive officers and senior management; • administering the equity incentive plans and other benefit programs; 14